The Food and Drug Administration on Friday approved the first nonhormonal medication to treat hot flashes in menopausal women, offering a potential remedy for the symptoms of overheating of the upper body and sweating that can be disruptive to daily life for years.The drug, to be marketed as Veozah, is the first to target a neuron in the brain that becomes unbalanced as estrogen levels fall.
[
add
]
[
|
|
...
]